Testosterone Gel 5% is a transdermal androgen research gel supplied in a 60 pump format. Manufactured for consistent potency, stable transdermal delivery, and controlled research applications.
AndroGel is a pharmaceutical transdermal testosterone gel formulation delivering 1% testosterone. This presentation supplied in 5.0g packets, double the gel volume per packet compared to CSD’s 2.5g AndroGel listing at the same concentration. The 30 packet supply provides a one month research quantity at standard once daily application, with the higher per packet gram weight delivering a greater total testosterone mass per application than the 2.5g packets.
The 5.0g and 2.5g packet sizes serve distinct research procurement purposes within CSD’s AndroGel range. Clinical transdermal testosterone literature references variable daily gram dosing based on target serum testosterone concentration and individual absorption characteristics, the 5.0g packet accommodates higher daily gram dosing protocols without requiring multiple smaller packets per application, while the 2.5g packet suits lower dose research or protocols where finer dose titration through packet combination is the priority. Both deliver identical 1% concentration testosterone gel, with packet size and resulting per application gram dose representing the primary differentiating variable between the two listings.
Transdermal testosterone delivery operates through percutaneous absorption across the skin barrier into systemic circulation, a pharmacokinetic pathway fundamentally distinct from injectable ester delivery, producing a relatively stable daily concentration profile without the peak and trough pattern of injectable testosterone. Absorption efficiency varies based on application site, skin condition, and individual factors. Research variables that make gram dose per application a meaningful pharmacokinetic consideration, and one that the 5.0g packet size addresses directly for protocols requiring higher total testosterone delivery per application event. As with all transdermal testosterone formulations, secondary transfer risk through skin contact remains a documented consideration distinct from injectable, oral, or peptide delivery routes.
Every batch of CSD’s AndroGel is third party verified for concentration accuracy and purity, with documentation available on request. Canada Steroid Depot stocks AndroGel across both 2.5g and 5.0g packet sizes, giving researchers gram dose flexibility within the same 1% concentration formulation from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at room temperature away from direct light and heat. Wash hands thoroughly after application. Intended for research purposes only.
Commonly researched alongside injectable testosterone esters in comparative transdermal versus parenteral bioavailability studies. Browse CSD’s full TRT and injectable testosterone range for complete sourcing.
$350.00
